What Is the “Learned Intermediary” Doctrine in Georgia Pharmaceutical Cases?
On this page
It is the rule that a manufacturer of a prescription drug or medical device owes its duty to warn to the prescribing doctor, not the patient. The Supreme Court of Georgia stated it in McCombs v. Synthes (U.S.A.) (2003): the manufacturer “does not have a duty to warn the patient of the dangers involved with the product, but instead has a duty to warn the patient’s doctor, who acts as a learned intermediary between the patient and the manufacturer”. The warning to the doctor must itself be adequate.
The rule and its reason
McCombs gave the reason in the words of earlier decisions: the treating physician is in a better position to warn the patient, because “decision to employ prescription medication [or medical devices] involves professional assessment of medical risks in light of the physician’s knowledge of a patient’s particular need and susceptibilities”. The doctrine follows from that structure: the patient obtains the product only through a doctor’s professional judgment.
Devices are covered as well as drugs
McCombs itself was a device case. The patient had spinal surgery in which a plate was installed to stabilize her spine; the plate later fractured, and she sued the manufacturer for failure to warn. The Court’s statement of the rule names “the manufacturer of a prescription drug or medical device”.
The limit: the doctor’s warning must be adequate
The doctrine moves the warning to the doctor; it does not excuse a weak warning. McCombs recorded the manufacturer’s own concession that “under the learned intermediary doctrine, the manufacturer’s warnings to the physician must be adequate or reasonable under the circumstances of the case”. The case turned on that question: the Supreme Court reversed the Court of Appeals for refusing to consider the patient’s argument that the warning given to her surgeon was inadequate, and sent the case back for that argument to be decided.
So a failure-to-warn claim in a prescription case asks:
- What warning did the manufacturer give the prescribing or implanting doctor?
- Did that warning adequately describe the risk that caused the injury?
- Would an adequate warning have changed the doctor’s decision or what the doctor told the patient?
How warning adequacy is analyzed in other product cases is explained in what you must prove in a Georgia failure-to-warn claim.
Direct-to-consumer advertising
McCombs states the Georgia rule without any exception for products a manufacturer advertises directly to patients. A claim built on consumer advertising therefore starts from the doctor-directed rule in Georgia, and any argument for a different duty has to be made against that rule.
How this connects to claims against the doctor
The doctrine addresses the manufacturer’s duty. The prescribing or implanting physician has a separate duty to disclose certain risks before covered procedures under Georgia’s informed consent statute; see when lack of informed consent supports a malpractice claim. A claim against a physician is a malpractice claim with its own affidavit and deadline rules.
Sources
General information about Georgia law as of October 2026. It is not legal advice, and reading it does not create an attorney-client relationship.